A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: Enhanced vasorelaxation and increased endothelial nitric oxide synthase expression

American Heart Journal

Volumn 144, Issue 1, 2002, Pages 165-172

  Kuvin, Jeffrey T ^a   Rämet, Maria E ^a   Patel, Ayan R ^a   Pandian, Natesa G ^a   Mendelsohn, Michael E ^a   Karas, Richard H ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOENZYME; LOW DENSITY LIPOPROTEIN; NICOTINIC ACID; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM; VASODILATATION; VITAMIN SUPPLEMENTATION;

EID: 0036301760     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.123145     Document Type: Article

References (43)

1. Factors involved in the maintenance of endothelial function
2. Endothelial function: Does it matter? Is it reversible?
3. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart
4. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
5. Clinical implications of endothelial dysfunction
6. Endothelial function as an end-point in interventional trials: Concepts, methods and current data
7. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
8. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
9. Non-invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility
10. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
11. Need for standardization of non-invasive assessment of vascular endothelial function
12. Close relation of endothelial function in the human coronary and peripheral circulations
13. Long-term prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain
14. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
15. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
16. Randomized trial of cholesterol lowering 444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
17. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
18. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
19. Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study
20. HDL cholesterol levels predict survival in men after coronary artery bypass graft surgery: 20-Year experience from the Cleveland Clinic Foundation
21. High density lipoprotein cholesterol and mortality: The Framingham Heart Study
22. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
23. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
24. The antiatherogenic role of high-density lipoprotein cholesterol
25. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules
26. Endothelial dysfunction in human disease
27. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication
28. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
29. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients
30. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia
31. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
32. Technical aspects of evaluating brachial artery vasodilation using high-frequency ultrasound
33. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
34. Ethanol-induced redistribution of cholesteryl ester transfer protein (CETP) between lipoproteins
35. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
36. Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy
37. High density lipoprotein inhibits the oxidative modification of low density lipoprotein
38. Pathogenesis of acute myocardial infarction: Novel regulatory systems of bioactive substances in the vessel wall
39. Pathophysiology of reverse cholesterol transport: Insights from inherited disorders of lipoprotein metabolism
40. Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia
41. Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia
42. Enhancement of metabolic coronary vasodilatation by nicotinic acid or amide
43. Aspirin improves endothelial dysfunction in atherosclerosis